Estrella Immunopharma, Inc. Common Stock (ESLA)

NASDAQ: ESLAUSD
1.05 USD
-0.02 (-2.14%)
AT CLOSE (11:59 AM EDT)
1.05
-0.00 (-0.29%)
POST MARKET (AS OF 06:06 PM EDT)
🔴Market: CLOSED
Open?$1.07
High?$1.10
Low?$1.05
Prev. Close?$1.05
Volume?10.4K
Avg. Volume?50.4K
VWAP?$1.05
Rel. Volume?0.21x
Bid / Ask
Bid?$1.03 × 100
Ask?$1.08 × 100
Spread?$0.05
Midpoint?$1.06
Valuation & Ratios
Market Cap?44.8M
Shares Out?42.7M
Float?10.2M
Float %?27.1%
P/E Ratio?N/A
P/B Ratio?-4.32
EPS?-$0.31
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.12Weak
Quick Ratio?0.12Weak
Cash Ratio?0.10Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
-4.32CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-3.3CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
126.0%STRONG
ROA?
-411.2%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$43.4M
Related Companies
Loading...
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
44.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098